172 related articles for article (PubMed ID: 19098448)
21. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
Clin Cancer Res; 2003 Apr; 9(4):1441-5. PubMed ID: 12684417
[TBL] [Abstract][Full Text] [Related]
22. Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis.
Anupam K; Tusharkant C; Gupta SD; Ranju R
World J Gastroenterol; 2006 Oct; 12(37):6041-5. PubMed ID: 17009406
[TBL] [Abstract][Full Text] [Related]
23. Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma.
Zhao BJ; Sun DG; Zhang M; Tan SN; Ma X
Dis Esophagus; 2009; 22(1):55-61. PubMed ID: 18564167
[TBL] [Abstract][Full Text] [Related]
24. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
[TBL] [Abstract][Full Text] [Related]
25. p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions.
Roth MJ; Abnet CC; Hu N; Wang QH; Wei WQ; Green L; D'Alelio M; Qiao YL; Dawsey SM; Taylor PR; Woodson K
Oncol Rep; 2006 Jun; 15(6):1591-7. PubMed ID: 16685400
[TBL] [Abstract][Full Text] [Related]
26. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation.
Dong SW; Cui YT; Zhong RR; Liang DC; Liu YM; Wang YG; He Z; Wang S; Liang SJ; Zhang P
Clin Lab; 2012; 58(1-2):41-51. PubMed ID: 22372344
[TBL] [Abstract][Full Text] [Related]
27. Hypermethylation of the GATA gene family in esophageal cancer.
Guo M; House MG; Akiyama Y; Qi Y; Capagna D; Harmon J; Baylin SB; Brock MV; Herman JG
Int J Cancer; 2006 Nov; 119(9):2078-83. PubMed ID: 16823849
[TBL] [Abstract][Full Text] [Related]
28. RASSF1A gene promoter methylation in esophageal cancer specimens.
Yamaguchi S; Kato H; Miyazaki T; Sohda M; Kimura H; Ide M; Asao T; Kuwano H
Dis Esophagus; 2005; 18(4):253-6. PubMed ID: 16128782
[TBL] [Abstract][Full Text] [Related]
29. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
[TBL] [Abstract][Full Text] [Related]
30. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
31. Methylation silencing of TGF-β receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma.
Ma Y; He S; Gao A; Zhang Y; Zhu Q; Wang P; Yang B; Yin H; Li Y; Song J; Yue P; Li M; Zhang D; Liu Y; Wang X; Guo M; Jiao Y
Clin Epigenetics; 2020 Feb; 12(1):25. PubMed ID: 32046777
[TBL] [Abstract][Full Text] [Related]
32. [Hypermethylation of promoter region of RAS association domain family gene1A in esophageal squamous cell carcinoma and significance thereof].
Cong DG; Wang SF
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2932-4. PubMed ID: 18261310
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
[TBL] [Abstract][Full Text] [Related]
34. Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus.
Guo M; Ren J; House MG; Qi Y; Brock MV; Herman JG
Clin Cancer Res; 2006 Aug; 12(15):4515-22. PubMed ID: 16899597
[TBL] [Abstract][Full Text] [Related]
35. Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling.
Cao B; Yang W; Jin Y; Zhang M; He T; Zhan Q; Herman JG; Zhong G; Guo M
J Thorac Oncol; 2016 Nov; 11(11):1912-1926. PubMed ID: 27374455
[TBL] [Abstract][Full Text] [Related]
36. Hypermethylation of promoter region of LATS1--a CDK interacting protein in oral squamous cell carcinomas--a pilot study in India.
Reddy VR; Annamalai T; Narayanan V; Ramanathan A
Asian Pac J Cancer Prev; 2015; 16(4):1599-603. PubMed ID: 25743838
[TBL] [Abstract][Full Text] [Related]
37. [Correlation of aberrant methylation of MGMT gene to MTHFR C677T genetic polymorphisms in esophageal squamous cell carcinoma].
Xue HC; Wang JM; Xu B; Guo GP; Hua ZL; Zhou Q; Zhu ZH; Ma ZK; Gao J
Ai Zheng; 2008 Dec; 27(12):1256-62. PubMed ID: 19079989
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic deregulations of Wnt/β-catenin and transforming growth factor beta-Smad pathways in esophageal cancer: Outcome of DNA methylation.
Singh V; Singh AP; Sharma I; Singh LC; Sharma J; Borthakar BB; Rai AK; Kataki AC; Kapur S; Saxena S
J Cancer Res Ther; 2019; 15(1):192-203. PubMed ID: 30880778
[TBL] [Abstract][Full Text] [Related]
39. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM
Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic silencing of ZNF132 mediated by methylation-sensitive Sp1 binding promotes cancer progression in esophageal squamous cell carcinoma.
Jiang D; He Z; Wang C; Zhou Y; Li F; Pu W; Zhang X; Feng X; Zhang M; Yecheng X; Xu Y; Jin L; Guo S; Wang J; Wang M
Cell Death Dis; 2018 Dec; 10(1):1. PubMed ID: 30578410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
